Vandana G Abramson (Vandana Abramson)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Squamous Cell Carcinoma

Positive Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, Chau Dang, Denise A Yardley, Steven Jay Isakoff, Vicente Valero, Meredith Faggen, Therese Marie Mulvey, Ron Bose, Douglas Weckstein, Antonio C Wolff, Katherine E Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Audrey Merrill Garrett, P Kelly Marcom, Kathy S Albain, Patricia DeFusco, Nadine M Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana G Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Adrienne G Waks, Michelle DeMeo, Harold J Burstein, Ann H Partridge, Patrizia Dell'Orto, Leila Russo, Emma Krause, Daniel J Newhouse, Busem Binboğa Kurt, Elizabeth A Mittendorf, Bryan Paul Schneider, Adrienne G Waks, Eric P Winer, Ian E Krop, Sara M Tolaney, null null, null null
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Elizabeth C Wescott, Xiaopeng Sun, Paula I Gonzalez Ericsson, Ann Hanna, Brandie C Taylor, Violeta Sanchez, Juliana Bronzini, Susan R Opalenik, Melinda E Sanders, Julia D Wulfkuhle, Rosa I Gallagher, Henry L Gómez, Claudine Isaacs, Vijaya Bharti, John Tanner Wilson, Tarah Jean Ballinger, Cesar A Santa-Maria, Payal Deepak Shah, Elizabeth C Dees, Brian D Lehmann, Vandana G Abramson, Gillian L Hirst, Lamorna Brown Swigart, Laura van 't Veer, Laura J Esserman, Emanuel F Petricoin, Jennifer A Pietenpol, Justin M Balko
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer. Cancer research communications 4 (4) (2024)
Adrienne G Waks, Emily L Chen, Noah Graham, Anna Mae Frey, Kenneth Almeida, Victoria Attaya, Victoria Attaya, Ibrahim M Abbass, Anita Fung, Jesse Sussell, Patricia Cortazar, Caroline Harvey, Denise Leth, Meredith Faggen, Natalie Sinclair, Jeanna Walsh, Nadine M Tung, Sarah Sinclair, Steve Lo, Denise Yardley, Vicente Valero, Jane Meisel, Tarah Jean Ballinger, Sylvia Adams, Lisa Anne Carey, Julia K Rauch, Vandana G Abramson, Nicole O Williams, Wendy Y Chen, José Pablo Leone, Susan T Schumer, Nabihah Tayob, Sara M Tolaney
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial). JCO oncology practice (2024)
Elizabeth C Wescott, Xiaopeng Sun, Paula I Gonzalez Ericsson, Ann Hanna, Brandie C Taylor, Violeta Sanchez, Juliana Bronzini, Susan R Opalenik, Melinda E Sanders, Julia D Wulfkuhle, Rosa I Gallagher, Henry L Gómez, Claudine Isaacs, Vijaya Bharti, John Tanner Wilson, Tarah Jean Ballinger, Cesar A Santa-Maria, Payal Deepak Shah, Elizabeth C Dees, Brian D Lehmann, Vandana G Abramson, Gillian L Hirst, Lamorna Brown Swigart, Laura van 't Veer, Laura J Esserman, Emanuel F Petricoin, Jennifer A Pietenpol, Justin M Balko
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer. Cancer research communications 4 (4) (2024)
Eric M Lander, Katherine C Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G Abramson
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer. The oncologist 28 (2) (2023)
Eric M Lander, Katherine C Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G Abramson
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer. The oncologist 28 (2) (2023)
Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez Ericsson, Violeta Sanchez, Melinda E Sanders, Elizabeth C Wescott, Susan R Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry L Gómez, Claudine Isaacs, Tarah Jean Ballinger, Cesar A Santa-Maria, Payal Deepak Shah, Elizabeth C Dees, Brian D Lehmann, Vandana G Abramson, Jennifer A Pietenpol, Justin M Balko
NKG2A is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple Negative Breast Cancer. Cancer discovery (2023)
Eric M Lander, Katherine C Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G Abramson
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer. The oncologist 28 (2) (2023)
Eric M Lander, Katherine C Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G Abramson
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer. The oncologist (2022)
Sara M Tolaney, Nabihah Tayob, Chau Dang, Denise A Yardley, Steven Jay Isakoff, Vicente Valero, Meredith Faggen, Therese Marie Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C Wolff, Katherine E Reeder-Hayes, Hope S Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Paul Schneider, Audrey Merrill Garrett, P Kelly Marcom, Kathy S Albain, Patricia DeFusco, Nadine M Tung, Blair Ardman, Rita Nanda, Rachel C Jankowitz, Mothaffar F Rimawi, Vandana G Abramson, Paula R Pohlmann, Catherine H Van Poznak, Andres Forero-Torres, Minetta C Liu, Kathryn J Ruddy, Yue Zheng, Shoshana M Rosenberg, Richard D Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann H Partridge, Eric P Winer, Ian E Krop
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
Otto Metzger Filho, Giuseppe Viale, Shayna Stein, Lorenzo Trippa, Denise A Yardley, Ingrid A Mayer, Vandana G Abramson, Carlos L Arteaga, Laura M Spring, Adrienne G Waks, Eileen Wrabel, Michelle K DeMeo, Aditya Bardia, Patrizia Dell'Orto, Leila Russo, Tari A King, Kornelia Polyak, Franziska Michor, Eric P Winer, Ian E Krop
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab. Cancer discovery 11 (10) (2021)
Chi Yan, Jinming Yang, Nabil Saleh, Sheau-Chiann Chen, Gregory D Ayers, Vandana G Abramson, Ingrid A Mayer, Ann Richmond
Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer. International journal of molecular sciences 22 (10) (2021)
Caitriona Cahir, Jeffrey P Leal, Lilja Solnes, Chiung-Yu Huang, Ashley Carpenter, Katy Gaffney, Vandana G Abramson, Lisa Anne Carey, Minetta C Liu, Mothaffar F Rimawi, Jennifer M Specht, Anna Maria V Storniolo, Vicente Valero, Christos Vaklavas, Ian E Krop, Eric P Winer, Melissa Camp, Robert S Miller, Antonio C Wolff, Ashley Cimino-Mathews, Ben Ho Park, Richard L Wahl, Vered Stearns
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (20) (2021)
Priyanka Sharma, Vandana G Abramson, Anne O'Dea, Lauren E Nye, Ingrid Mayer, Harsh B Pathak, Marc Hoffmann, Shane R Stecklein, Manana Elia, Sharon Lewis, Jecinta Scott, Jilliann A De Jong, Yen Y Wang, Rachel Yoder, Kelsey Schwensen, Karissa Finke, Jaimie Heldstab, Stephanie LaFaver, Stephen K Williamson, Milind A Phadnis, Gregory A Reed, Bruce F Kimler, Qamar J Khan, Andrew K Godwin
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Margaret L Axelrod, Mellissa J Nixon, Paula I Gonzalez Ericsson, Riley E Bergman, Mark A Pilkinton, Wyatt J McDonnell, Violeta Sanchez, Susan R Opalenik, Sherene Loi, Jing Zhou, Sean Mackay, Brent N Rexer, Vandana G Abramson, Valerie M Jansen, Simon A Mallal, Joshua Donaldson, Sara M Tolaney, Ian E Krop, Ana Christina Garrido-Castro, Jonathan D Marotti, Kevin Shee, Todd W Miller, Melinda E Sanders, Ingrid A Mayer, Roberto Salgado, Justin M Balko
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (21) (2020)
Ian Krop, Vandana G Abramson, Marco Colleoni, Tiffany Traina, Frankie Ann Holmes, Laura Garcia-Estevez, Lowell Hart, Ahmad Awada, Claudio Zamagni, Patrick G Morris, Lee Schwartzberg, Stephen Chan, Ayca Gucalp, Laura Biganzoli, Joyce Steinberg, Lorenzo Sica, Maureen Trudeau, Denka Markova, Jamal C Tarazi, Zhou Zhu, Thomas O'Brien, Catherine M Kelly, Eric P Winer, Denise A Yardley
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, Erica L Mayer, Tufia C Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R Nangia, Paula I Gonzalez Ericsson, Violeta Sanchez, Kimberly N Johnson, Richard G Abramson, Sheau-Chiann Chen, Yu Shyr, Carlos L Arteaga, Antonio C Wolff, Jennifer A Pietenpol, null null
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (9) (2019)
Vandana G Abramson, Mafalda Oliveira, Andrés Cervantes, Hans Wildiers, Manish R Patel, Todd M Bauer, Philippe L Bedard, Carlos Becerra, Stephen Richey, Michael C Wei, Eric Reyner, John Bond, Na Cui, Timothy R Wilson, Heather M Moore, Cristina Saura, Ian E Krop
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer. Breast cancer research and treatment 178 (1) (2019)